https://adisinsight.springer.com/drugs/800038976?error=cookies_not_supported&code=c23aab8a-9ed9-40a1-936a-b9d339a8f6d1
Research programme: antibody-based cancer therapeutics - Genexine/Nascent Biologics - AdisInsight
Genexine in South Korea and Nascent Biotech (previously Nascent Biologics) in the US are co-developing antibody-based therapies for brain cancer. Development is
research programmecancer therapeuticsantibodybasednascent
https://veraxa.com/
Superior Cancer Therapeutics Using Transformative Innovations
At VERAXA Biotech, we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics.
cancer therapeuticssuperiorusingtransformativeinnovations
https://www.insights10.com/report/qatar-breast-cancer-therapeutics-market-analysis/
Qatar Breast Cancer Therapeutics Market Report 2022 to 2030
The Qatar breast cancer therapeutics market is projected to grow from $73 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of...
breast cancermarket reportqatartherapeutics
https://www.insights10.com/report/spain-kidney-cancer-therapeutics-market-analysis/
Spain Kidney Cancer Therapeutics Market Report 2023 to 2030
Spain's kidney cancer therapeutics market was valued at $121.40 Mn in 2023, projected to reach $158.25 Mn by 2030 with a 3.86% CAGR.
kidney cancermarket reportspaintherapeutics
https://uberant.com/article/2056617-united-states-head-and-neck-cancer-therapeutics-market-dynamics-key-players-and-industry-projections-till-2029-by-tec/
United States Head and Neck Cancer Therapeutics Market: Dynamics, Key Players, and Industry...
the market is anticipated to witness significant growth in the coming years.
head and neck cancerunited states
https://www.ijsr.net/getabstract.php?paperid=SR221013113123
Cancer Therapeutics and Delivery Strategies of Bioactive Peptides
New therapies are constantly evolving in man?s fight aimed towards successful prevention and treatment of cancer. This paper discusses the role of peptides in c
cancer therapeuticsdeliverystrategiesbioactivepeptides
https://esciencenews.com/dictionary/cancer.therapeutics
Learn more about cancer therapeutics | (e) Science News
learn more aboutcancer therapeuticssciencenews
https://www.usprwire.com/Detailed/Health_Wellbeing/_Colorectal_Cancer_Therapeutics_in_Major_Developed_Markets_to_2020_Published_332172.shtml
"Colorectal Cancer Therapeutics in Major Developed Markets to 2020" Published | USPRWire
colorectal cancerdeveloped marketstherapeuticsmajor
https://physicistparticle.com/dr-jill-p-smith-cancer-therapeutics-best-researcher-award-2746/
Cancer Therapeutics Innovation Award to Dr. Jill P. Smith
Honoring Dr. Jill P. Smith for her groundbreaking research and excellence in advancing cancer therapeutics and translational oncology.
cancer therapeuticsinnovation awarddrjillsmith
https://markets.businessinsider.com/news/stocks/briacell-receptor-ai-collaborate-on-ai-small-molecular-cancer-therapeutics-1035582996
BriaCell, Receptor.AI collaborate on AI small molecular cancer therapeutics | Markets Insider
BriaCell (BCTX) Therapeutics announces that its subsidiary, BriaPro Therapeutics, has initiated a research collaboration with Receptor.AI, an AI...
cancer therapeuticsreceptoraicollaborate
https://straitsresearch.com/report/prostate-cancer-therapeutics-market/request-sample
Prostate Cancer Therapeutics Market Size, Global Trends And Report Analysis by 2033
Request Free Sample : The global prostate cancer therapeutics market size is projected to grow from USD 14.33 billion in 2025 to USD 27.55 billion by 2033,...
prostate cancermarket sizeglobal trends
https://www.reanin.com/reports/lung-cancer-therapeutics-market
Lung Cancer Therapeutics Market Size & Share
Lung Cancer Therapeutics Market was valued at USD 23,347.41 million in the year 2025. The size of this market is expected to increase to USD 44,635.98 million...
lung cancermarket sizetherapeuticsshare
https://www.hilcovs.co.uk/sale-list/project-franklin/
Biopharmaceutical Company with Innovative Cancer Therapeutics in Clinical Trials - Hilco Valuation...
biopharmaceutical companycancer therapeuticsclinical trialsinnovative
https://www.contrivedatuminsights.com/product-report/anal-cancer-therapeutics-market-11831
Anal Cancer Therapeutics Market Growth, And Opportunities (2023-2030): Contrive Datum Insights
Global Anal Cancer Therapeutics Market Is Exhibiting A CAGR Of 6.3% during the Forecast Period. Report provides vital industry insights that will help...
anal cancermarket growth
https://hoajonline.com/index.php/jctr/fee
Article-Processing Charge | Journal of Cancer Therapeutics & Research
article processing chargejournal of cancertherapeuticsresearch
https://adisinsight.springer.com/drugs/800045833?error=cookies_not_supported&code=f8a7a2ed-60dd-4943-8f51-8a3d75dba7de
Research programme: cancer therapeutics - ED Laboratories - AdisInsight
ED Laboratories is developing small-molecule lead compounds for the treatment of glioblastoma and retinoblastoma. Longer term, the company intends on developing
research programmecancer therapeuticsedlaboratories
https://straitsresearch.com/report/cervical-cancer-therapeutics-market
Cervical Cancer Therapeutics Market Size, Demand, Report to 2033
The global cervical cancer therapeutics market size is projected to grow from USD 6.61 billion in 2025 to USD 9.38 billion by 2033, exhibiting a CAGR of 4.47%.
cervical cancermarket sizedemand reporttherapeutics
https://www.precedenceresearch.com/press-release/cancer-therapeutics-and-biotherapeutics-market
Cancer Therapeutics and Biotherapeutics Market Size, Report 2032
The cancer therapeutics and biotherapeutics market size is anticipated to touch around USD 379.07 billion by 2032 from USD 183.43 billion in 2023 with a CAGR...
cancer therapeuticsmarket sizebiotherapeuticsreport
https://www.ycombinator.com/companies/origin-bio
Origin: AI and Data for Cancer Therapeutics | Y Combinator
AI and Data for Cancer Therapeutics. Founded in 2025 by Malhar Bhide and Yash Rathod, Origin has 4 employees based in San Francisco.
ai and datacancer therapeuticsorigincombinator
https://investingnews.com/tag/cancer-therapeutics
cancer therapeutics | INN
cancer therapeuticsinn
https://www.beckersoncology.com/oncology/banner-md-anderson-opens-cancer-therapeutics-research-institute/
Banner MD Anderson opens cancer therapeutics research institute - Becker's Oncology
Feb 11, 2022 - Gilbert, Ariz.-based Banner MD Anderson Cancer Center launched a cancer therapeutics research institute, AZBigMedia reported Feb. 10.
md andersoncancer therapeuticsresearch institutebanneropens
https://bridgeinformatics.com/bioinformatics-data-mining-for-targeted-cancer-therapeutics/
Bioinformatics Data Mining for Targeted Cancer Therapeutics - Bridge Informatics
Oct 17, 2024 - Situation Our Client, a biotechnology company developing novel cancer therapeutics, needed to identify cancer types containing a specific cell population of...
data miningcancer therapeuticsbioinformaticstargetedbridge
https://www.benthamscience.com/ebook_volume/3495/related-ebooks
Ebook - Molecular Targets and Cancer Therapeutics (Part 2) | Bentham Science
molecular targetscancer therapeuticsebookpartbentham
https://www.bioxbio.com/journal/MOL-CANCER-THER
Molecular Cancer Therapeutics Impact Factor IF 2025|2024|2023 - BioxBio
Molecular Cancer Therapeutics Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1535-7163.
cancer therapeuticsimpact factormolecular
https://researchexperts.utmb.edu/en/publications/computational-drug-repositioning-for-cancer-therapeutics/
Computational drug repositioning for cancer therapeutics - UTMB Health Research Expert Profiles
cancer therapeuticshealth researchcomputationaldrugrepositioning
https://www.verifiedmarketresearch.com/product/south-america-bladder-cancer-therapeutics-and-diagnostics-market/
South America Bladder Cancer Therapeutics and Diagnostics Market Report: Size, Growth, Trends &...
Apr 9, 2025 - South America Bladder Cancer Therapeutics and Diagnostics Market size was valued at $1866.0 Mn by 2032, growing at a CAGR of 10.4% from 2026 to 2032 The report...
south americabladder cancer
https://skysonginnovations.com/technology_category/non-cancer-therapeutics/page/3/
Non-Cancer Therapeutics Archives - Page 3 of 8 - Skysong Innovations
cancer therapeuticsarchives pagenoninnovations
https://www.surety.com/news/press-releases/cancer-therapeutics-crc
Cancer Therapeutics CRC Implements AbsoluteProof
Australian pharmaceutical company recognizes need to demonstrate timeline of discoveries and prove IP inventorship for legal defensibility.
cancer therapeuticscrcimplements
https://www.bradford.ac.uk/ict/
Institute of Cancer Therapeutics - University of Bradford
The Institute of Cancer Therapeutics (ICT) is a multidisciplinary team of researchers at the University of Bradford working together to research, develop and...
cancer therapeuticsinstituteuniversitybradford
https://www.astuteanalytica.com/industry-report/japan-pet-cancer-therapeutics-market
Japan Pet Cancer Therapeutics Market Report [2033]
Japan Pet Cancer Therapeutics Market is projected to reach USD 29.1 Million by 2033, growing at a CAGR of 7.3% from 2025-2033.
pet cancermarket reportjapantherapeutics
https://hoajonline.com/index.php/jctr/indexing
Indexing & Archiving | Journal of Cancer Therapeutics & Research
journal of cancerindexingarchivingtherapeuticsresearch
https://www.bradford.ac.uk/postgraduate/profiles/hannah-19214/
Hannah, PhD, Institute of Cancer Therapeutics - Student profiles - University of Bradford
cancer therapeuticsstudent profileshannahphdinstitute
https://www.custommarketinsights.com/press-releases/breast-cancer-therapeutics-market-size/
Global Breast Cancer Therapeutics Market Size $66.1 Bn 2033
Apr 2, 2024 - Global Breast Cancer Therapeutics Market size is likely to reach USD 66.1 Billion by 2033 expanding at a CAGR of 6.8% from 2024 to 2033 by CMI
breast cancermarket sizeglobaltherapeuticsbn
https://www.researchandmarkets.com/reports/5513581/lung-cancer-therapeutics-market-2025-2029
Lung Cancer Therapeutics Market 2025-2029 - Research and Markets
This report features 20 companies, including F. Hoffmann La Roche Ltd., Novartis AG, Amgen Inc., Boehringer Ingelheim International GmbH, Sanofi SA,...
lung cancertherapeuticsmarketresearch
https://www.researchandmarkets.com/reports/5998258/prostate-cancer-therapeutics-market-size-market
Prostate Cancer Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook,...
Prostate Cancer Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
prostate cancermarket sizetherapeuticsshareapplication
https://www.globenewswire.com/fr/news-release/2024/01/04/2803903/0/en/Lung-Cancer-Therapeutics-Market-Size-Worth-USD-57-69-Billion-in-2032-Emergen-Research.html
Lung Cancer Therapeutics Market Size Worth USD 57.69
Increasing adoption of unhealthy lifestyle and rising demand for targeted therapies are key factors driving market revenue growth...
lung cancermarket sizetherapeuticsworthusd
https://www.c-further.org/
C-Further | Children's Cancer Therapeutics Consortium | C-Further
C-Further aims to create more effective, targeted medicines for children and young people with cancer, bridging the gap between the lab and patients.
cancer therapeuticschildrenconsortium
https://adisinsight.springer.com/drugs/800038976?error=cookies_not_supported&code=c23aab8a-9ed9-40a1-936a-b9d339a8f6d1
Research programme: antibody-based cancer therapeutics - Genexine/Nascent Biologics - AdisInsight
Genexine in South Korea and Nascent Biotech (previously Nascent Biologics) in the US are co-developing antibody-based therapies for brain cancer. Development is
research programmecancer therapeuticsantibodybasednascent
https://www.grinstaff.org/cancer-biology-and-therapeutics.html
Cancer Biology and Therapeutics - THE GRINSTAFF GROUP
Cancer is a leading cause of death in the developed world. Antineoplastic therapy focuses on systemic treatments for metastatic disease, a point at which...
cancer biologytherapeuticsgroup
https://www.bahamasbusinesstimes.com/article/854944491-xilio-therapeutics-announces-upcoming-presentations-at-the-society-for-immunotherapy-of-cancer-sitc-40th-annual-meeting
Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer...
https://veraxa.com/
Superior Cancer Therapeutics Using Transformative Innovations
At VERAXA Biotech, we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics.
cancer therapeuticssuperiorusingtransformativeinnovations
https://www.insights10.com/report/qatar-breast-cancer-therapeutics-market-analysis/
Qatar Breast Cancer Therapeutics Market Report 2022 to 2030
The Qatar breast cancer therapeutics market is projected to grow from $73 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of...
breast cancermarket reportqatartherapeutics
https://www.insights10.com/report/spain-kidney-cancer-therapeutics-market-analysis/
Spain Kidney Cancer Therapeutics Market Report 2023 to 2030
Spain's kidney cancer therapeutics market was valued at $121.40 Mn in 2023, projected to reach $158.25 Mn by 2030 with a 3.86% CAGR.
kidney cancermarket reportspaintherapeutics
https://research.childrensnational.org/center-for-cancer-and-immunology/research/micro-and-nanotechnology
Micro and Nanotechnology for Cancer Biology and Therapeutics - Center for Cancer & Immunology...
This program develops and uses cutting edge technologies in chip-based microdevices for personalized drug screening or basic research and nanoparticle-based...
cancer biologymicronanotechnologytherapeuticscenter
https://edoc.mdc-berlin.de/id/eprint/26377/
Design of combination therapeutics from protein response to drugs in ovarian cancer cells - MDC...
https://uberant.com/article/2056617-united-states-head-and-neck-cancer-therapeutics-market-dynamics-key-players-and-industry-projections-till-2029-by-tec/
United States Head and Neck Cancer Therapeutics Market: Dynamics, Key Players, and Industry...
the market is anticipated to witness significant growth in the coming years.
head and neck cancerunited states
https://pharsight.greyb.com/therapeutics/postmenopausal-metastatic-breast-cancer
Drug Therapeutics of Postmenopausal Metastatic Breast Cancer
A detailed list of the drug therapeutics of Postmenopausal Metastatic Breast Cancer, along with the patent title, drug patent expiry date, ingredients,...
metastatic breastdrugtherapeuticscancer
https://www.dkkreativekonsulting.com/group/mysite-200-group/discussion/dcfcf34f-efb5-4a58-b8f4-73229ce1e722
Key Drivers Behind the $78 Billion Blood Cancer Therapeutics | Group | Dk Kreative Konsulti
Oct 22, 2025 - Key Drivers Behind the $78 Billion Blood Cancer Therapeutics Market Growth Description: Examining the demographic, disease-related, and technological factors...
https://www.ijsr.net/getabstract.php?paperid=SR221013113123
Cancer Therapeutics and Delivery Strategies of Bioactive Peptides
New therapies are constantly evolving in man?s fight aimed towards successful prevention and treatment of cancer. This paper discusses the role of peptides in c
cancer therapeuticsdeliverystrategiesbioactivepeptides
https://www.bioworld.com/articles/714933-rondo-therapeutics-reports-cd28-x-nectin-4-bispecific-antibody-for-bladder-cancer?v=preview
Rondo Therapeutics reports CD28 x Nectin-4 bispecific antibody for bladder cancer | BioWorld
Nectin-4 antibody-drug conjugate (ADC) and checkpoint inhibitor combinations have represented a great advancement in the treatment of bladder cancer, but...
https://ezine-articles.com/lung-cancer-therapeutics-market-research-and-clinical-analysis-2024-to-2030/
Lung Cancer Therapeutics Market Research and Clinical Analysis 2024 to 2030 - ezine articles
Aug 31, 2024 - The Lung Cancer Therapeutics Market presents an accurate and strategic analysis of the industry. The report includes a comprehensive investigation into the...
https://esciencenews.com/dictionary/cancer.therapeutics
Learn more about cancer therapeutics | (e) Science News
learn more aboutcancer therapeuticssciencenews
https://www.usprwire.com/Detailed/Health_Wellbeing/_Colorectal_Cancer_Therapeutics_in_Major_Developed_Markets_to_2020_Published_332172.shtml
"Colorectal Cancer Therapeutics in Major Developed Markets to 2020" Published | USPRWire
colorectal cancerdeveloped marketstherapeuticsmajor
https://www.prbd.net/news_54245.aspx
prbd - Reports and Intelligence: Ovarian Cancer Therapeutics in Major Developed Markets to 2020
https://www.espervita.com/
Giving Hope to Cancer Patients for a Better Life | Espervita Therapeutics
Espervita Therapeutics is focused on the discovery of therapies to treat cancers in areas with significant unmet medical need. Learn more about what we do.
for a better lifegiving hopecancer patients
https://vcapital.com/news/intensity-therapeutics-presents-positive-int230-6-data-in-patients-with-early-stage-breast-cancer/
Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Early-Stage Breast Cancer -...
https://physicistparticle.com/dr-jill-p-smith-cancer-therapeutics-best-researcher-award-2746/
Cancer Therapeutics Innovation Award to Dr. Jill P. Smith
Honoring Dr. Jill P. Smith for her groundbreaking research and excellence in advancing cancer therapeutics and translational oncology.
cancer therapeuticsinnovation awarddrjillsmith
https://www.bioworld.com/articles/699431-eil-therapeutics-divulges-new-bcl-2-inhibitors-for-cancer?v=preview
Eil Therapeutics divulges new Bcl-2 inhibitors for cancer | BioWorld
Eil Therapeutics Inc. has synthesized apoptosis regulator Bcl-2 inhibitors reported to be useful for the treatment of cancer.
eiltherapeuticsnewbclinhibitors
https://www.healthcarejournaloregon.com/article/835820872-silexion-therapeutics-announces-new-preclinical-data-showing-up-to-97-inhibition-of-cancer-cell-growth-including-new-evidence-against-new-previously
Silexion Therapeutics Announces New Preclinical Data Showing Up to 97% Inhibition of Cancer Cell...
https://www.deepscienceventures.com/articles/leading-cancer-biologists-and-entrepreneurs-join-enedra-therapeutics-as-co-founders
Leading Cancer Biologists and Entrepreneurs Join Enedra Therapeutics as Co-Founders - DeepScience...
Enedra Therapeutics, a therapeutics company within the Deep Science Ventures portfolio, announces that it is adding a number of seasoned industry executives as...
https://gsbs.uth.edu/events/event?id=f3dc54c8-6a2e-4eb5-9093-8e484f797f11
Therapeutics and Pharmacology Lunch and Learn - Events - MD Anderson Cancer Center UTHealth...
MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Event: Therapeutics and Pharmacology Lunch and Learn
md anderson cancer centerlearn eventstherapeuticspharmacologylunch
https://markets.businessinsider.com/news/stocks/briacell-receptor-ai-collaborate-on-ai-small-molecular-cancer-therapeutics-1035582996
BriaCell, Receptor.AI collaborate on AI small molecular cancer therapeutics | Markets Insider
BriaCell (BCTX) Therapeutics announces that its subsidiary, BriaPro Therapeutics, has initiated a research collaboration with Receptor.AI, an AI...
cancer therapeuticsreceptoraicollaborate